Cardiology
CHF
More in CHF
Cardiac myosin inhibitor linked to improvements in biomarkers in small study
Vast majority of trial participants responded to aficamten
Benefit of the nonsteroidal MRA otherwise consistent across FINEARTS-HF
Recent developments of interest in cardiovascular medicine
Meta-analysis holds LGE higher than LVEF in identifying high-risk NIDCM
Recent developments of interest in cardiovascular medicine
Study lays out common gaps in evidence both before and after approval
Recent developments of interest in cardiovascular medicine
Continued OAC failed to meet noninferiority in POPular PAUSE TAVI
Recent developments of interest in cardiovascular medicine
Randomized trial shows benefits beyond heart failure with low ejection fraction, but not survival
NOTION-3 trial informs care for those with severe AS and stable CAD
RESHAPE-HF2 has provocative implications for a wider pool of TEER candidates
Randomized trial "highly encouraging" for making patients feel and function better
